Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marilisa Franceschi

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Medicine|August 26, 2018
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centersAntonio Tursi, Walter Elisei, Roberto Faggiani, et al.
European Journal of Internal Medicine|June 19, 2019
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centersAntonio Tursi, Giammarco Mocci, Roberto Faggiani, et al.
European Journal of Gastroenterology & Hepatology|March 20, 2021
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatientsAntonio Tursi, Giammarco Mocci, Roberto Lorenzetti, et al.
Gut|October 27, 2021
Prognostic performance of the 'DICA' endoscopic classification and the 'CODA' score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort studyAntonio Tursi, Giovanni Brandimarte, Francesco Di Mario, et al.
United European Gastroenterology Journal|August 8, 2023
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysisAntonio Tursi, Daniele Piovani, Giovanni Brandimarte, et al.
Annals of Surgery|October 26, 2012
Barrett's esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA)Massimo Rugge, Giovanni Zaninotto, Paola Parente, et al.
Intestinal Research|August 12, 2024
Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international studyAntonio Tursi, Daniele Piovani, Giovanni Brandimarte, et al.
The American Journal of Gastroenterology|June 14, 2023
Prevalence and Natural History of Segmental Colitis Associated With DiverticulosisAntonio Tursi, Daniele Piovani, Giovanni Brandimarte, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Medicine|August 26, 2018
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centersAntonio Tursi, Walter Elisei, Roberto Faggiani, et al.
European Journal of Internal Medicine|June 19, 2019
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centersAntonio Tursi, Giammarco Mocci, Roberto Faggiani, et al.
European Journal of Gastroenterology & Hepatology|March 20, 2021
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatientsAntonio Tursi, Giammarco Mocci, Roberto Lorenzetti, et al.
Gut|October 27, 2021
Prognostic performance of the 'DICA' endoscopic classification and the 'CODA' score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort studyAntonio Tursi, Giovanni Brandimarte, Francesco Di Mario, et al.
United European Gastroenterology Journal|August 8, 2023
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysisAntonio Tursi, Daniele Piovani, Giovanni Brandimarte, et al.
Annals of Surgery|October 26, 2012
Barrett's esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA)Massimo Rugge, Giovanni Zaninotto, Paola Parente, et al.
Intestinal Research|August 12, 2024
Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international studyAntonio Tursi, Daniele Piovani, Giovanni Brandimarte, et al.
The American Journal of Gastroenterology|June 14, 2023
Prevalence and Natural History of Segmental Colitis Associated With DiverticulosisAntonio Tursi, Daniele Piovani, Giovanni Brandimarte, et al.
Pageof 7